Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001611535-14-000002

Options or other derivatives

  • Director acquired 258,364.28 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mayne Pharma Ventures Pty Ltd Director 2014-06-24 Grant or award · Series A Convertible Preferred Stock +258,363.28 258,363.28 D
Mayne Pharma Ventures Pty Ltd Director 2014-06-24 Grant or award · Common Stock Purchase Warrant +1 1 D
Loading xslF345X03/primary_doc.xml…